ClinicaliQ Trial Snapshot
- Improving Patient Assessment After Acute Kidney Injury (AKI) — Recruiting • Cardiology / Cardiovascular • NCT07569588.
- What is being tested: The trial evaluates whether cystatin C or serum creatinine is a more reliable biomarker for assessing kidney function recovery following acute kidney injury (AKI), with three integrated study components to address this question.
- Patient eligibility overview: The trial includes adult patients who have experienced acute kidney injury, though specific inclusion/exclusion criteria would determine exact recruitment parameters across the three trial components.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The goal of this clinical trial is to improve patient care after acute kidney injury (AKI). It has three related parts. The main questions it aims to answer are: 1. Is creatinine or cystatin a more reliable assessment of kidney function after AKI? 2. What are the experiences of patients after AKI? 3. What interventions should be recommended to improve assessment and support of patients after AKI? Participants will be asked to do one or more of: * blood tests to measure kidney function in different ways * have measurement…
Eligibility Snapshot
- : Observational study workstream * Age 18-85 years * AKI stage 2 or 3 during hospital admission OR AKI stage 1 of at least 7 days duration during hospital admission * 60-90 days after peak creatinine Qualitative interview workstream * Age 18-85 years * AKI during hospital admission * 60-90 days after peak creatinine Participatory workshop workstream * Age 18-85 years * Relevant experience (as assessed by the investigator) which could include personal experience of an episode of hospitalised AKI as a patient of carer, experience of managing AKI or related problems in a professional capacity or knowledge of a particular community.
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.